News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Organetix, Inc. (DMND) Commences New Patient Study Relating To Quality Of Life For Hepatitis C Patients


10/19/2005 5:11:30 PM

Organetix Inc. (OTCBB: OGTX) has commenced a new patient study to ascertain the effectiveness of its A4+L Liver Product relating to the quality of life of Hepatitis C patients.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES